James N. Wilson, President, Oncology at CORCEPT THERAPEUTICS INC (CORT), sold 58,435 shares at $109.35 ($6.5M) on 2026-09-02, disclosed to the SEC on 2026-09-03.
Scheduled sale ($6.5M) by President, Oncology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $109.35 | 23,600 | $2.6M | 39.9% |
| 2 | $110.70 | 23,770 | $2.6M | 40.7% |
| 3 | $111.37 | 1,537 | $171K | 2.6% |
| 4 | $112.40 | 974 | $109K | 1.7% |
| 5 | $113.38 | 102 | $12K | 0.2% |
| 6 | $113.72 | 1,606 |
| $183K |
| 2.8% |
| 7 | $114.58 | 5,621 | $644K | 10.0% |
| 8 | $115.44 | 1,225 | $141K | 2.2% |
| Total | $110.76 avg | 58,435 | $6.5M | 100% |
| Filing → |